Company Overview
IMMUNOCORE HOLDINGS PLC
IMCRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
400M
2025 FY
Net Income
-36M
2025 FY
Shares Outstanding
50M
2025 FY
EPS
-0.71USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1671927
Exchange
Nasdaq
Location
GB